Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 2, 2007, Pages 146-151

  McIntosh, Alyson ^a   Freedman, Gary ^a   Eisenberg, Debra ^a   Anderson, Penny ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast conservation; Radiation therapy; Resection margins

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CARCINOMA IN SITU; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PATIENT ABANDONMENT; RADIATION DOSE; RECURRENCE RISK; RESEARCH; TREATMENT REFUSAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; PARTICLE ACCELERATORS; RECEPTORS, ESTROGEN; RECURRENCE; REOPERATION; TIME FACTORS;

EID: 34147144948     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000251357.45879.7f     Document Type: Article

References (43)

1. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719 -725.
2. Stotter AT, McNeese MD, Ames FC, et al. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer. 1989;64:2217-2225.
3. Kurtz JM, Spitalier J-M, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1990;18:87-93.
4. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907-911.
5. Haffty BG, Reiss M, Beinfield M, et al. ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996;14:52-57.
6. Arriagada R, Lê MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol. 1996;14:1558-1564.
7. Kim SH, Simkovich-Heerdt A, Tran KN, et al. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg. 1998;187:1-8.
8. Cowen D, Jacquemier J, Houvenaeghel G, et al. Local and distant recurrence after conservative management of 'very low-risk' breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys. 1998;41:801-807.
9. Touboul E, Buffat L, Belkacémi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25-38.
10. Fortin A, Larochelle M, Laverdière J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17:101-109.
11. Meijer-van Gelder ME, Look MP, Bolt-de Vries J, et al. Breast-conserving therapy: proteases as risk factors in relation to survival after local relapse. J Clin Oncol. 1999;17:1449-1457.
12. Kini VR, Vicini FA, Frazier R, et al. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys. 1999;43:341-346.
13. van Dongen J, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-1150.
14. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
15. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999;44:1005-1015.
16. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 1998;40:851-858.
17. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer. 1995;76:259-267.
18. Park CC, Mitsumori MM, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668-1675.
19. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1,973 patients. Eur J Cancer. 1995;31A:1574-1579.
20. Obedian E, Haffty BG. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am. 1999;6:28-33.
21. Cowen D, Houvenaeghel G, Bardou V-J, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for nodenegative breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:305-312.
22. Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol. 1994;12:653-660.
23. Peterson ME, Schultz DJ, Reynolds C, et al. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 1999;43:1029-1035.
24. Dewar JA, Arriagada R, Benhamou S, et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). Cancer. 1995;76:2260-2265.
25. Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996;334:1356-1361.
26. DiBiase SJ, Komarnicky LT, Schwartz GF, et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer. 1998;82:2212-2220.
27. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996;78:1921-1928.
28. Ryoo MC, Kagan AR, Wollin M, et al. Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma. Radiology. 1989;172:555-559.
29. Pezner RD, Terz J, Ben-Ezra J, et al. Now there are two effective conservation approaches for patients with stage I and II breast cancer: how pathological assessment of inked resection margins can provide valuable information for the radiation oncologist. Am J Clin Oncol. 1990;13:175-179.
30. Solin LJ, Fowble BL, Schultz DJ, et al. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:279-287.
31. Krishnan L, Jewell WR, Krishnan EC, et al. Breast cancer with extensive intraductal component: treatment with immediate interstitial boost irradiation. Radiology. 1992;183:273-276.
32. Spivack B, Khanna MM, Tafra L, et al. Margin status and local recurrence after breast-conserving surgery. Arch Surg. 1994;129:952-957.
33. Slotman BJ, Meyer OWM, Njo KH, et al. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 1994;30:206-212.
34. Heimann R, Powers C, Halpern HJ, et al. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience. Cancer. 1996;78:1722-1730.
35. Pittinger TP, Maronian NC, Poulter CA, et al. Importance of margin status in outcome of breast-conserving surgery for carcinoma. Surgery. 1994;116:605-609.
36. Leborgne F, Leborgne JH, Ortega B, et al. Breast conservation treatment of early stage breast cancer: patterns of failure. Int J Radiat Oncol Biol Phys. 1995;31:765-775.
37. Freedman G, Hanlon A, Fowble B, et al. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast conserving surgery and radiation. J Clin Oncol. 2002;20:4015-4021.
38. Fowble B. Conservative surgery and radiation for early breast cancer. In: Fowble B, Goodman R, Glick J, et al, eds. Breast Cancer Treatment: A Comprehensive Guide to Management. St. Louis: Mosby Yearbook; 1991:105-149.
39. Schnitt SJ, Connolly JL, Harris JR, et al. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984;53:1049-1057.
40. Chism DB, Freedman GM, Li T, et al. Re-excision of margins before breast radiation - diagnostic or therapeutic? Int J Radiat Oncol Biol Phys. 2006;65:1416-1421.
41. Thurman SA, Schnitt SJ, Connolly JL, et al. Outcome after breastconserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:152-159.
42. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;60:772-730.
43. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys. 1999;45:885-891.